The Effects of Ischemic Conditioning in Individuals with Parkinson's Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-90
SponsorHospital Israelita Albert Einstein

About this trial

Ischemic conditioning (IC) is a promising therapy that can mimic the physiological effects of physical exercise. IC consists of using a cuff to measure blood pressure and calibrate 200 mmHg on the upper or lower limb. Thus, at alternating intervals of 5 minutes, ischemia or reperfusion occurs, depending on whether the cuff is inflated or deflated. IC induces changes in spinal cord excitability for the last reflex reactions of recruited motoneurons with improved balance control in healthy young people and improved learning in the elderly. The objective of the present study is to evaluate the chronic effect of IC on the motor function and cognitive performance of patients with Parkinson's disease. Furthermore, the investigators will evaluate secondary outcomes such as mobility, quality of life, and immunological responses.

Eligibility criteria

Qualifiers

PD patients aged 40 years or older;

Diagnosis of PD without cognitive complaints or with complaints, but without impact on daily activities;

Disqualifiers

Patients with uncontrolled diabetes mellitus or peripheral neuropathy;

Uncontrolled arterial hypertension (BP>160/100mmHg);

Uncontrolled diabetes (Fasting glucose > 250mg/dl, peripheral retinopathy or diabetic ketoacidosis);

Uncontrolled dyslipidemia (total chol > 220mg/dL);

Trial design

Treatments tested in this trial

  • Ischemic conditioning group
  • Sham group

Treatment groups

34 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Hospital Israelita Albert Einstein

Lead sponsor

Unifesp Escola Paulista de Medicina

Collaborator